Related Experiment Videos
Aggressive surgical resection for cholangiocarcinoma
W K Washburn1, W D Lewis, R L Jenkins
1Division of Hepatobiliary Surgery and Liver Transplantation, New England Deaconess Hospital, Boston, Mass.
Archives of Surgery (Chicago, Ill. : 1960)
|March 1, 1995
Summary
Aggressive surgical resection significantly improves survival for cholangiocarcinoma patients. Nonoperative palliation with stents is recommended for unresectable cases, offering better outcomes than surgical palliation.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastroenterology
Background:
- Cholangiocarcinoma presents a significant challenge in hepatobiliary surgery.
- Understanding survival predictors is crucial for treatment planning.
Purpose of the Study:
- To review cholangiocarcinoma cases over an 8-year period.
- To evaluate survival predictors and the efficacy of aggressive surgical resection.
- To assess outcomes of surgical and nonoperative palliation.
Main Methods:
- Retrospective review of 88 cholangiocarcinoma patients.
- Univariate analysis of clinical and pathological factors.
- Comparison of survival between resected, surgically palliated, and nonoperatively palliated patients.
Main Results:
- Survival correlates with pathological stage (TNM); tumor location is not a factor.
- Resected patients (median 23.2 months) survived longer than palliated patients (median 7.7 months).
- Nonoperative palliation (wire mesh stents) yielded better survival than surgical palliation (P = .045).
Conclusions:
- Aggressive surgical resection with free margins significantly improves cholangiocarcinoma patient survival.
- Hepatic resection offers survival benefits, with low morbidity and mortality.
- Nonoperative stenting is advocated for unresectable cholangiocarcinoma.